SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity

mRNA-based vaccines dramatically reduce the occurrence and severity of COVID-19, but are associated with rare vaccine-related adverse effects. These toxicities, coupled with observations that SARS-CoV-2 infection is associated with autoantibody development, raise questions whether COVID-19 vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaycox, Jillian R., Lucas, Carolina, Yildirim, Inci, Dai, Yile, Wang, Eric Y., Monteiro, Valter, Lord, Sandra, Carlin, Jeffrey, Kita, Mariko, Buckner, Jane H., Ma, Shuangge, Campbell, Melissa, Ko, Albert, Omer, Saad, Lucas, Carrie L., Speake, Cate, Iwasaki, Akiko, Ring, Aaron M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996559/
https://www.ncbi.nlm.nih.gov/pubmed/36894554
http://dx.doi.org/10.1038/s41467-023-36686-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996559/
https://www.ncbi.nlm.nih.gov/pubmed/36894554
http://dx.doi.org/10.1038/s41467-023-36686-8

Ejemplares similares